Geovax Labs, INC. (GOVX) — 10-Q Filings

10-Q Filings (6)

• GeoVax's Cash Dwindles Amidst Rising Losses, Government Revenue Plummets — Nov 13, 2025 Risk: high
  GeoVax Labs, Inc. reported a net loss of $6,318,914 for the three months ended September 30, 2025, an increase from a net loss of $5,815,468 for the same period
• GeoVax Raises $1M in July Offering Amidst Zero Revenue — Jul 28, 2025 Risk: high
  GeoVax Labs, Inc. reported no revenue for the six months ended June 30, 2025, consistent with the prior year period. The company's net loss for the six months e
• GeoVax Labs Files Q1 2025 10-Q — May 1, 2025 Risk: medium
  GeoVax Labs, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates, including information r
• GeoVax Labs Files Q3 2024 10-Q, Details ATM Program & BARDA Contract — Nov 12, 2024 Risk: medium
  GeoVax Labs, Inc. filed its Q3 2024 10-Q report on November 12, 2024, covering the period ending September 30, 2024. The company is involved in the pharmaceutic
• GeoVax Labs Q2 2024: Financing Activities Highlighted — Aug 6, 2024 Risk: medium
  GeoVax Labs, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial performance and business activities. Key events disc
• GeoVax Labs, Inc. Files 10-Q for Q1 2024 — May 14, 2024 Risk: low
  GeoVax Labs, Inc. (GOVX) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. GeoVax Labs, Inc. filed a 10-Q for the period ending March 31, 2024. The

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX